Edan Instruments, Inc. (SHE:300206)
11.70
-0.13 (-1.10%)
Oct 17, 2025, 3:04 PM CST
Edan Instruments Revenue
Edan Instruments had revenue of 493.45 million CNY in the quarter ending June 30, 2025, with 3.12% growth. This brings the company's revenue in the last twelve months to 1.83 billion, up 3.15% year-over-year. In the year 2024, Edan Instruments had annual revenue of 1.83 billion, down -5.35%.
Revenue (ttm)
1.83B
Revenue Growth
+3.15%
P/S Ratio
3.71
Revenue / Employee
717.20K
Employees
2,546
Market Cap
6.78B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.83B | -103.61M | -5.35% |
Dec 31, 2023 | 1.94B | 195.58M | 11.22% |
Jan 1, 2023 | 1.74B | 106.00M | 6.48% |
Dec 31, 2021 | 1.64B | -682.19M | -29.42% |
Dec 31, 2020 | 2.32B | 1.18B | 104.06% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Huadong Medicine | 42.62B |
WuXi AppTec | 41.90B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |
Shanghai Fosun Pharmaceutical (Group) | 40.12B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Jiangsu Hengrui Medicine | 30.15B |
Zhejiang NHU Company | 22.87B |
Aier Eye Hospital Group | 21.94B |